Overview

AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

Status:
Active, not recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the effects that the study drug (OPC) has on AGE levels in patients with ER+ metastatic breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Medical University of South Carolina
Treatments:
Metformin